Literature DB >> 15119171

Frequent ventricular extrasystole treated by needling neiguan (PC 6) plus oral administration of mexiletine--a report of 30 cases.

Jingzu Zhang1, Wenhua Xu.   

Abstract

PURPOSE: To observe the therapeutic effect of needling at Neiguan (PC 6) plus oral administration of mexiletine.
METHODS: 60 cases of frequent ventricular extrasystole were randomly divided into two groups: a treatment group, and a control group. In the control group, mexiletine was orally administered, and in the treatment group needling at bilateral Neiguan (PC 6) plus oral administration of mexiletine were given. 2 weeks of treatments constituted a therapeutic course.
RESULTS: Of the 30 cases in the treatment group, 23 cases were markedly effective, 5 cases improved, and 2 cases failed; while in the control group 16 cases were markedly effective, 8 cases improved, 4 cases failed, and 2 cases aggravated. The total effective rates of 90.3% and 80.0%, respectively in the treatment and control groups showed a very significant difference between the two groups (P < 0.01).
CONCLUSION: Needling at bilateral Neiguan (PC 6) may enhance the therapeutic effect for frequent ventricular extrasystole.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15119171

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  2 in total

1.  P6 Electroacupuncture Improved QTc Interval Prolongation by Upregulation of Connexin43 in Droperidol Treated Rats.

Authors:  Feng Zhao; Suyang Cui; Libing Huang
Journal:  Evid Based Complement Alternat Med       Date:  2014-10-13       Impact factor: 2.629

2.  Comparative Effectiveness of Acupuncture and Antiarrhythmic Drugs for the Prevention of Cardiac Arrhythmias: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Yanda Li; Hector Barajas-Martinez; Bo Li; Yonghong Gao; Zhenpeng Zhang; Hongcai Shang; Yanwei Xing; Dan Hu
Journal:  Front Physiol       Date:  2017-06-08       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.